THE IMPACT OF PROPHYLAXIS CHEMOTHERAPY ON CENTRAL NERVOUS SYSTEM (CNS) RELAPSES OF HIGH RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A NETWORK META-ANALYSIS

被引:0
|
作者
Haddad, Philip [1 ]
Hammoud, Dalia [1 ]
Gallagher, Kevin [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Overton Brooks VAMC, Shreveport, LA 71105 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NCOG-04
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [21] Incidence and survival patterns of primary central nervous system (CNS), systemic and concurrent diffuse large B-cell lymphoma (DLBCL).
    Mukkamalla, Shiva Kumar Reddy
    Naseri, Hussain M.
    Sahai, Tanmay
    Roberts, Todd F.
    Malik, Mohsin Ilyas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Reply to Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma
    Abramson, Jeremy S.
    Hochberg, Ephraim P.
    [J]. CANCER, 2011, 117 (11) : 2580 - 2581
  • [23] CNS prophylaxis for diffuse large B-cell lymphoma
    Eyre, Toby A.
    Savage, Kerry J.
    Cheah, Chan Y.
    El-Galaly, Tarec C.
    Lewis, Katharine L.
    McKay, Pamela
    Wilson, Matthew R.
    Evens, Andrew M.
    Bobillo, Sabela
    Villa, Diego
    Maurer, Matthew J.
    Cwynarski, Kate
    Ferreri, Andres
    [J]. LANCET ONCOLOGY, 2022, 23 (09): : E416 - E426
  • [24] Incidence and Risk Factors for Central Nervous System (CNS) Relapse In Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis with Competing Risk Regression (CRR) Model
    Chihara, Dai
    Oki, Ysuhiro
    Matsuo, Keitaro
    Onoda, Hiroshi
    Taji, Hirofumi
    [J]. BLOOD, 2010, 116 (21) : 1691 - 1691
  • [25] Diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) relapse: Prognosis and risk factors by retrospective analysis from single center experience
    Shimazu, Yutaka
    Maeda, Takeshi
    Notohara, Kenji
    Ito, Takeshi
    Morita, Satoko
    Fujiwara, Yayoi
    Uchiyama, Tatsuki
    Sato, Aki
    Sato, Takayuki
    Onishi, Tatsuhito
    Chisato, Mizutani
    Matsutama, Funtio
    Tsukayama, Choutatsu
    Ueda, Yasunori
    [J]. BLOOD, 2007, 110 (11) : 1007A - 1007A
  • [26] Evaluating the Impact of Prophylactic Intrathecal Chemotherapy in Diffuse Large B Cell Lymphoma (DLBCL) Patients with High Central Nervous System International Prognostic Index (CNS-IPI) Scores: A Comprehensive Review and Meta-Analysis
    Al-Banaa, Kadhim
    Alshaikhli, Alfarooq
    Poudel, Shyam
    Shrotria, Shiva
    Wang, Can
    Hanona, Paul
    Gopishetty, Swathi
    Idogun, Precious
    Ezekwudo, Daniel
    Jaiyesimi, Ishmael
    [J]. BLOOD, 2023, 142
  • [27] Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
    Zhang, Jing
    Chen, Bobin
    Xu, Xiaoping
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 509 - 514
  • [28] Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
    Korfel, Agnieszka
    [J]. CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 436 - 440
  • [29] The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis
    Lin, Zhijuan
    Chen, Xing
    Liu, Long
    Zeng, Hanyan
    Li, Zhifeng
    Xu, Bing
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [30] Multifocal Primary Central Nervous System (CNS) Diffuse Large B-Cell Lymphoma (DLBCL) in a Patient with Aquired Immunodeficiency Syndrome (AIDS)
    Khokhar, H.
    Wang, K.
    Luis, D.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 : S90 - S90